Harvard Bioscience, Inc. · NASDAQ:HBIO
Harvard Bioscience, Inc. shareholders
As of Jun 30, 2026, 33 institutions reported holding Harvard Bioscience, Inc., 29.7% of its shares. Largest: Weber Capital Management LLC, Vanguard and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Harvard Bioscience, Inc. | Change | Filed |
|---|---|---|---|---|
| Weber Capital Management LLC | 311K | 6.8% | −9,176 | Aug 13, 2026 |
| Vanguard | 199K | 4.4% | +6,312 | Aug 13, 2026 |
| Acadian Asset Management LLC | 180K | 3.9% | no change | Aug 13, 2026 |
| Corsair Capital Management, L.P. | 123K | 2.7% | −2,000 | Aug 14, 2026 |
| Two Sigma | 115K | 2.5% | +428 | Aug 14, 2026 |
| Renaissance Technologies | 99,327 | 2.2% | −2,100 | Aug 13, 2026 |
| BlackRock | 61,834 | 1.4% | −392 | Aug 7, 2026 |
| Geode Capital | 47,555 | 1.0% | −11,956 | Aug 12, 2026 |
| Mink Brook Asset Management LLC | 33,369 | 0.73% | new | Aug 14, 2026 |
| Millennium | 32,620 | 0.72% | −13,712 | Aug 14, 2026 |